bf/NASDAQ:CADL_icon.jpeg

NASDAQ:CADL

Candel Therapeutics, Inc.

  • Stock

USD

Last Close

10.70

15/05 20:00

Market Cap

34.85M

Beta: -

Volume Today

1.68M

Avg: 28.77K

PE Ratio

−2.46

PFCF: −1.09

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
125K
-
125K
0%
125K
0%
125K
0%
cost of revenue
6.61M
-
232K
-
987K
325.43%
1.20M
21.58%
gross profit
-6.48M
-
125K
101.93%
-107K
185.60%
-862K
705.61%
-1.20M
39.21%
selling and marketing expenses
general and administrative expenses
2.56M
-
5.18M
102.78%
10.67M
106.00%
14.06M
31.73%
13.88M
1.24%
selling general and administrative expenses
2.56M
-
5.18M
102.78%
10.67M
106.00%
14.06M
31.73%
13.88M
1.24%
research and development expenses
6.61M
-
8.75M
32.50%
15.18M
73.38%
20.79M
36.95%
23.31M
12.12%
other expenses
-571K
-
-624K
9.28%
-1.08M
72.44%
-48K
95.54%
cost and expenses
8.59M
-
13.31M
54.94%
24.77M
86.12%
34.80M
40.46%
38.39M
10.32%
operating expenses
8.59M
-
13.31M
54.94%
24.77M
86.12%
34.80M
40.46%
37.19M
6.87%
interest expense
53K
-
490K
824.53%
-2.60M
629.59%
ebitda
-7.58M
-
-8.49M
12.02%
-24.42M
187.61%
-51.04M
109.04%
-37.19M
27.14%
operating income
-9.04M
-
-13.81M
52.82%
-25.73M
86.29%
-34.72M
34.97%
-38.39M
10.57%
depreciation and amortization
1.46M
-
5.32M
264.88%
1.31M
75.41%
-16.32M
1,347.86%
1.20M
107.35%
total other income expenses net
797K
-
-3.87M
585.57%
-10.40M
168.68%
15.93M
253.18%
452K
97.16%
income before tax
-8.24M
-
-17.68M
114.56%
-36.12M
104.32%
-18.79M
47.97%
-37.94M
101.87%
income tax expense
-226K
-
4.49M
2,088.50%
53K
98.82%
-15.93M
30,152.83%
net income
-8.01M
-
-22.17M
176.69%
-36.18M
63.15%
-2.87M
92.08%
-37.94M
1,223.76%
weighted average shs out
29.15M
-
29.15M
0%
28.69M
1.57%
28.82M
0.47%
28.94M
0.39%
weighted average shs out dil
29.15M
-
29.15M
0%
28.69M
1.57%
28.82M
0.47%
28.94M
0.39%
eps
-0.27
-
-0.76
181.48%
-1.26
65.79%
-0.10
92.11%
-1.31
1,217.91%
epsdiluted
-0.27
-
-0.76
181.48%
-1.26
65.79%
-0.10
92.11%
-1.31
1,217.91%

All numbers in USD (except ratios and percentages)